EYA3
Protein phosphatase EYA3
Also known as: DKFZp686C132, EYA3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99504
- Gene
- EYA3
- Ensembl
- ENSG00000158161
- Chromosome
- 1
- Canonical length
- 573 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may act as a transcriptional activator and have a role during development. It can act as a mediator of chemoresistance and cell survival in Ewing sarcoma cells, where this gene is up-regulated via a micro-RNA that binds to the 3' UTR of the transcript. A similar protein in mice acts as a transcriptional activator. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Canonical amino-acid sequenceUniProt
573 residues, UniProt reviewed canonical sequence.
>Q99504|EYA3
1 MEEEQDLPEQ PVKKAKMQES GEQTISQVSN PDVSDQKPET SSLASNLPMS EEIMTCTDYI
61 PRSSNDYTSQ MYSAKPYAHI LSVPVSETAY PGQTQYQTLQ QTQPYAVYPQ ATQTYGLPPF
121 GALWPGMKPE SGLIQTPSPS QHSVLTCTTG LTTSQPSPAH YSYPIQASST NASLISTSST
181 IANIPAAAVA SISNQDYPTY TILGQNQYQA CYPSSSFGVT GQTNSDAEST TLAATTYQSE
241 KPSVMAPAPA AQRLSSGDPS TSPSLSQTTP SKDTDDQSRK NMTSKNRGKR KADATSSQDS
301 ELERVFLWDL DETIIIFHSL LTGSYAQKYG KDPTVVIGSG LTMEEMIFEV ADTHLFFNDL
361 EECDQVHVED VASDDNGQDL SNYSFSTDGF SGSGGSGSHG SSVGVQGGVD WMRKLAFRYR
421 KVREIYDKHK SNVGGLLSPQ RKEALQRLRA EIEVLTDSWL GTALKSLLLI QSRKNCVNVL
481 ITTTQLVPAL AKVLLYGLGE IFPIENIYSA TKIGKESCFE RIVSRFGKKV TYVVIGDGRD
541 EEIAAKQHNM PFWRITNHGD LVSLHQALEL DFLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EYA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 14 nTPM
- kidney: 11 nTPM
- testis: 11 nTPM
- cerebellum: 9.7 nTPM
- retina: 9.7 nTPM
- esophagus: 9.6 nTPM
Single-cell type
- renal connecting tubule cells: 494 nCPM
- early primary spermatocytes: 253 nCPM
- renal collecting duct principal cells: 227 nCPM
- renal collecting duct intercalated cells: 227 nCPM
- distal convoluted tubule cells: 212 nCPM
- choroid plexus epithelial cells: 205 nCPM
Immune cell
- myeloid DC: 8.3 nTPM
- gdT-cell: 7.4 nTPM
- eosinophil: 7.3 nTPM
- NK-cell: 7.1 nTPM
- intermediate monocyte: 6.9 nTPM
- classical monocyte: 6.7 nTPM
Brain region
- choroid plexus: 22 nTPM
- cerebellum: 20 nTPM
- hypothalamus: 17 nTPM
- thalamus: 17 nTPM
- white matter: 17 nTPM
- amygdala: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.94
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- cell differentiation
- double-strand break repair
- negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
- positive regulation of DNA repair
- response to ionizing radiation
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EYA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EYA3 as an antibody target. Whether an autoantibody or antibody against EYA3 could matter depends on whether native EYA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EYA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EYA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...